A carregar...
A Multidrug, Antiproteinuric Approach to Alport Syndrome: A Ten-Year Cohort Study
BACKGROUND/AIMS: Combined ACE inhibitor, angiotensin-receptor-blocker, nondihydropyridine calcium-channel-blocker, and statin therapy (Remission Clinic) reduced proteinuria and halted progression in non-diabetic nephropathies, but its efficacy in Alport syndrome (AS) nephropathy is unknown. METHODS:...
Na minha lista:
| Publicado no: | Nephron |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4451141/ https://ncbi.nlm.nih.gov/pubmed/25895746 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000381480 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|